Sung Poblete Chief Executive Officer | Food Allergy Research & Education
+ Pharmaceuticals
Patient Daily | May 28, 2026

FARE receives investment from Soy Nutrition Institute Global for Mind Meld research initiative

FARE (Food Allergy Research & Education) announced on May 28 a collaborative research investment from Soy Nutrition Institute Global and U.S. Soy to advance its Mind Meld research initiative. The Mind Meld initiative is designed as a collaborative model to accelerate the development of new treatment options and ultimately seek a cure for food allergy.

Food allergy affects more than 33 million people in the United States, or about one in ten adults. FARE’s approach focuses on advancing solutions that improve the lives of those living with food allergies, while also promoting research aimed at prevention, better diagnosis, and a potential cure. The organization said continued research across allergens is important to reduce barriers to safe nutrition and increase access to trusted food options.

Sung Poblete, CEO of FARE, said, “For the growing number of patients living with food allergy and those who may develop the disease, the need for progress is urgent. The investment from SNI Global will support the use of a collaborative research model that has proven effective in cancer research and is now being applied to transform the future of food allergy. We’re grateful to SNI Global for joining with us to help advance this critical work because food is not the enemy—the disease is.”

Soy Nutrition Institute Global identifies, develops, and funds research into soy’s impact on human health. Although soy allergy occurs less frequently than other major allergens, ongoing study remains necessary to address barriers limiting access to this plant protein. Through its support of FARE’s Mind Meld initiative, SNI Global aims to promote multidisciplinary approaches against food allergies.

Julie Ohmen, CEO of SNI Global, said, “SNI Global is committed to advancing science that improves human health while also supporting the long-term sustainability of soybean farmers. Food allergy is a complex and growing disease that demands bold, coordinated action. FARE’s Mind Meld initiative has the potential to improve the lives of patients while strengthening confidence in the foods and agricultural systems that nourish communities around the world.”

SNI Global’s commitment will span multiple years with periodic review based on governance processes and organizational considerations.

Organizations in this story